​

Fortrea (FTRE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FTRE Stock Forecast

Fortrea (FTRE) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $19.50, with a high of $25.00 and a low of $15.00. This represents a 14.30% increase from the last price of $17.06.

$15 $21 $27 $33 $39 $45 High: $25 Avg: $19.5 Low: $15 Last Closed Price: $17.06

FTRE Stock Rating

Fortrea stock's rating consensus is Hold, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (33.33%), 7 Hold (58.33%), 1 Sell (8.33%), and 0 Strong Sell (0.00%).

Hold
Total 12 0 1 7 4 Strong Sell Sell Hold Buy Strong Buy

FTRE Price Target Upside V Benchmarks

TypeNameUpside
StockFortrea14.30%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts4916
Avg Price Target$20.25$17.22$14.19
Last Closing Price$17.06$17.06$17.06
Upside/Downside18.70%0.94%-16.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26-28-212
Dec, 25118-212
Nov, 25118-212
Oct, 25118-212
Sep, 25118-212
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 14, 2026Robert W. Baird$19.00$17.0511.44%11.37%
Jan 09, 2026Mizuho Securities$15.00$17.44-13.99%-12.08%
Jan 08, 2026Jailendra SinghTruist Financial$22.00$17.4925.79%28.96%
Jan 06, 2026Evercore ISI$25.00$16.6250.42%46.54%
Dec 18, 2025Ann HynesMizuho Securities$13.00$16.19-19.70%-23.80%
Dec 15, 2025Luke SergottBarclays$15.00$15.72-4.58%-12.08%
Dec 11, 2025Wedbush$21.00$16.2629.15%23.09%
Nov 07, 2025Ann HynesMizuho Securities$11.00$10.702.80%-35.52%
Nov 06, 2025Elizabeth AndersonEvercore ISI$14.00$11.2524.44%-17.94%
Oct 17, 2025Mizuho Securities$9.00$9.52-5.46%-47.25%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 22, 2026Cowen & Co.HoldHoldhold
Jan 06, 2026Evercore ISIOutperformOutperformupgrade
Dec 11, 2025CitigroupNeutralBuyupgrade
Oct 07, 2025CitigroupNeutralNeutralhold
Oct 02, 2025BarclaysUnderweightUnderweighthold
Sep 09, 2025JefferiesHoldHoldhold
Aug 07, 2025BarclaysUnderweightUnderweighthold
May 22, 2025CitigroupNeutralNeutralhold
May 14, 2025Cowen & Co.HoldHoldhold
May 13, 2025BarclaysUnderweightUnderweighthold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 $3 $4 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.04$-3.67----
Avg Forecast$1.44$0.51$1.29$1.72$2.30$2.96
High Forecast$1.47$0.55$1.52$2.09$2.41$3.06
Low Forecast$1.40$0.46$1.10$1.46$2.20$2.92
Surprise %-102.78%-819.61%----

Revenue Forecast

$3B $3B $3B $3B $3B $3B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.11B$2.70B----
Avg Forecast$3.11B$2.70B$2.73B$2.85B$2.97B$3.19B
High Forecast$3.12B$2.78B$2.78B$2.86B$3.01B$3.27B
Low Forecast$3.08B$2.67B$2.71B$2.84B$2.94B$3.15B
Surprise %-0.12%-0.23%----

Net Income Forecast

$-350M $-220M $-90M $40M $170M $300M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.40M$-328.50M----
Avg Forecast$127.73M$45.08M$116.21M$157.70M$204.37M$262.85M
High Forecast$130.84M$49.10M$134.61M$185.86M$213.61M$272.12M
Low Forecast$124.61M$41.06M$97.82M$129.54M$195.13M$258.96M
Surprise %-102.66%-828.71%----

FTRE Forecast FAQ

Is Fortrea stock a buy?

Fortrea stock has a consensus rating of Hold, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 7 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Fortrea is a neutral investment for most analysts.

What is Fortrea's price target?

Fortrea's price target, set by 12 Wall Street analysts, averages $19.5 over the next 12 months. The price target range spans from $15 at the low end to $25 at the high end, suggesting a potential 14.30% change from the previous closing price of $17.06.

How does Fortrea stock forecast compare to its benchmarks?

Fortrea's stock forecast shows a 14.30% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Fortrea over the past three months?

  • January 2026: 0% Strong Buy, 16.67% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.
  • December 2025: 8.33% Strong Buy, 8.33% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.
  • November 2025: 8.33% Strong Buy, 8.33% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.

What is Fortrea’s EPS forecast?

Fortrea's average annual EPS forecast for its fiscal year ending in December 2025 is $1.29, marking a -135.15% decrease from the reported $-3.67 in 2024. Estimates for the following years are $1.72 in 2026, $2.3 in 2027, and $2.96 in 2028.

What is Fortrea’s revenue forecast?

Fortrea's average annual revenue forecast for its fiscal year ending in December 2025 is $2.73B, reflecting a 1.22% increase from the reported $2.7B in 2024. The forecast for 2026 is $2.85B, followed by $2.97B for 2027, and $3.19B for 2028.

What is Fortrea’s net income forecast?

Fortrea's net income forecast for the fiscal year ending in December 2025 stands at $116.21M, representing a -135.38% decrease from the reported $-328M in 2024. Projections indicate $157.7M in 2026, $204.37M in 2027, and $262.85M in 2028.